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Impaired guanylyl cyclase activity (sGC) may be consid-
ered as a cardio-vascular risk factor. In order to study
such association with genetic tools, we investigated the
role of the GUCY 1A3 locus in genomewide association
studies as well as families with premature coronary artery
disease. We discovered genomewide significance for asso-
ciation between rs7692387 with coronary artery disease/
myocardial infarction in the CARDIoGRAMplusC4D
study. Moreover, we discovered mutations in the GUCY
1A3 gene in families with premature coronary disease.
Functional studies revealed that impaired guanylyl cyclase
activity was the most likely functional link between the
genetic variations and the increased risk of coronary
disease.
Published: 29 August 2013
doi:10.1186/2050-6511-14-S1-O6
Cite this article as: Schunkert: Genetic variants in guanylyl cyclase and
phoshodiesterase affecting coronary disease risk. BMC Pharmacology and
Toxicology 2013 14(Suppl 1):O6.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Correspondence: schunkert@dhm.mhn.de
Deutsches Herzzentrum München, Technische Universität München,
Lazarettstraße 36, Germany
Schunkert BMC Pharmacology and Toxicology 2013, 14(Suppl 1):O6
http://www.biomedcentral.com/2050-6511/14/S1/O6
© 2013 Schunkert; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
